Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings
About Vcanbio Cell & Gene Engineering Corp., Ltd
Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 中源协和细胞基因工程股份有限公司董事会审计委员会对会计师事务所履行监督职责情况报告 | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司对外提供财务资助管理办法 | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司关于公司2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司董事、高级管理人员薪酬管理制度 | 2026-04-24 | Chinese | |
| 独立董事候选人声明与承诺(张业炎) | 2026-04-24 | Chinese | |
| 中源协和细胞基因工程股份有限公司2025年年度报告 | 2026-04-24 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41331938 | 中源协和细胞基因工程股份有限公司董事会审计委员会对会计师事务所履行监督职责情况报告 | 2026-04-24 | Chinese | ||
| 41331932 | 中源协和细胞基因工程股份有限公司对外提供财务资助管理办法 | 2026-04-24 | Chinese | ||
| 41331925 | 中源协和细胞基因工程股份有限公司关于公司2025年度募集资金存放、管理与实际使用情况的专项报告 | 2026-04-24 | Chinese | ||
| 41331911 | 中源协和细胞基因工程股份有限公司董事、高级管理人员薪酬管理制度 | 2026-04-24 | Chinese | ||
| 41331904 | 独立董事候选人声明与承诺(张业炎) | 2026-04-24 | Chinese | ||
| 41331902 | 中源协和细胞基因工程股份有限公司2025年年度报告 | 2026-04-24 | Chinese | ||
| 41331900 | 中源协和细胞基因工程股份有限公司关于会计政策变更的公告 | 2026-04-24 | Chinese | ||
| 41331895 | 中源协和细胞基因工程股份有限公司重大风险和突发事件预警与应急处理制度 | 2026-04-24 | Chinese | ||
| 41331885 | 中源协和细胞基因工程股份有限公司内幕信息知情人管理制度 | 2026-04-24 | Chinese | ||
| 41331876 | 中源协和细胞基因工程股份有限公司关于计提资产减值损失的公告 | 2026-04-24 | Chinese | ||
| 41331863 | 中源协和细胞基因工程股份有限公司审计报告 | 2026-04-24 | Chinese | ||
| 41330857 | 中源协和细胞基因工程股份有限公司防范控股股东、实际控制人及其他关联方占用资金管理制度 | 2026-04-24 | Chinese | ||
| 41330846 | 中源协和细胞基因工程股份有限公司对会计师事务所履职情况的评估报告 | 2026-04-24 | Chinese | ||
| 41330844 | 中源协和细胞基因工程股份有限公司2025年度独立董事述职报告(罗明生) | 2026-04-24 | Chinese | ||
| 41330834 | 中源协和细胞基因工程股份有限公司自愿信息披露管理制度 | 2026-04-24 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
|
Abnova (Taiwan) Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
|
Achiko AG
A digital services platform for cross-border business compl…
|
ACHI | CH | Professional, scientific and te… |
Vcanbio Cell & Gene Engineering Corp., Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56891/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56891 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56891 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56891 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56891}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vcanbio Cell & Gene Engineering Corp., Ltd (id: 56891)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.